Maryland Becomes the First State to Cap What Government Health Plans Pay for Ozempic and Jardiance, Setting a $274 Monthly Limit That Could Reach Private Insurers by 2028
Maryland’s drug affordability board capped state and local government plan payments at $274 a month for Ozempic and $204 for Jardiance starting Jan. 1, 2027, the first such limit in the U.S., with a path to private insurers in 2028.
Read more
